Early Release / Consensus Report
Use of the BioFire® FilmArray® Pneumonia Plus Rapid Syndromic Multiplex PCR Assay in Pneumonia Patients – An Expert Opinion Report
Most Read
Abstract
This consensus report presents current expert opinions on the clinical use of the BioFire® FilmArray® Pneumonia Plus (PNplus) rapid molecular test in patients with pneumonia. A group of eight physicians with clinical experience in pneumonia identified common questions encountered in clinical practice regarding the use of PNplus for lower respiratory tract infections and developed consensus-based answers. Based on this process, a list of recommendations was compiled for the use of the PNplus rapid syndromic molecular test, which detects the most common bacteria, viruses, and resistance genes. These recommendations were supported by case examples based on fictional clinical scenarios, along with a proposed diagnostic algorithm for the management of pneumonia.
References
- Aydın M, Azak E, Bilgin H, et al. Changes in antimicrobial resistance and outcomes of health care-associated infections. Eur J Clin Microbiol Infect Dis. 2021;40(8):1737-42. [CrossRef]
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. [CrossRef]
- Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111. Erratum in: Clin Infect Dis. 2017;64(9):1298. Erratum in: Clin Infect Dis. 2017;65(8):1435. Erratum in: Clin Infect Dis. 2017;65(12):2161. [CrossRef]
- Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903. [CrossRef]
- Garau J, Baquero F, Pérez-Trallero E, et al; NACER Group. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect. 2008;14(4):322-9. [CrossRef]
- BIOFIRE® FILMARRAY® Pneumonia (PN) Panel product information [Internet]. Marcy-l’Étoile: bioMérieux. [erişim 13 Ağustos 2024]. https://www.biomerieux.com/us/en/our-offer/clinical-products/biofire-pneumonia-panel.html
- BIOFIRE® FILMARRAY® Pneumonia (PN) Panel Türkçe kullanım kılavuzu [Internet]. Marcy-l’Étoile: bioMérieux. [erişim 13 Ağustos 2024]. https://www.biomerieux.com/corp/en/our-offer/clinical-products/biofire-filmarray-pneumonia-panels.html
- Yoo IY, Huh K, Shim HJ, et al. Evaluation of the BioFire FilmArray Pneumonia Panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens. Int J Infect Dis. 2020;95:326-31. [CrossRef]
- Monard C, Pehlivan J, Auger G, et al; ADAPT study group. Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Crit Care. 2020;24(1):434. [CrossRef]
- Faron ML, Buchan BW, Ledeboer NA. Clinical evaluation and potential impact of a semi-quantitative multiplex molecular assay for the identification of pathogenic bacteria and viruses in lower respiratory specimens [poster presentation]. Presented at: American Thoracic Society Conference; 2018 May 20; San Diego, CA. https://www.biofiredx.com/wp-content/uploads/2018/08/Faron-M-et-al.-CVS.-2017..pdf
- Markussen DL, Serigstad S, Ritz C, et al. Diagnostic stewardship in community-acquired pneumonia with syndromic molecular testing: A randomized clinical trial. JAMA Netw Open. 2024;7(3):e240830. Erratum in: JAMA Netw Open. 2025;8(4):e258665. [CrossRef]
- Verroken A, Scohy A, Gérard L, Wittebole X, Collienne C, Laterre PF. Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis. Crit Care. 2020;24(1):410. [CrossRef]
- Zacharioudakis IM, Zervou FN, Dubrovskaya Y, Inglima K, See B, Aguero-Rosenfeld M. Evaluation of a multiplex PCR Panel for the microbiological diagnosis of pneumonia in hospitalized patients: Experience from an Academic Medical Center. Int J Infect Dis. 2021;104:354-60. [CrossRef]
- Edin A, Eilers H, Allard A. Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections. Infect Dis (Lond). 2020;52(7):479-88. [CrossRef]
- Dhesi Z, Enne VI, Brealey D. Organisms causing secondary pneumonias in COVID-19 patients at 5 UK ICUs as detected with the FilmArray® test [preprint]. medRxiv. 2020 Jun 23 [erişim 13 Ağustos 2024]. [CrossRef]
- Maataoui N, Chemali L, Patrier J, et al. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis. 2021;40(10):2227-34. [CrossRef]
- Gilbert DN, Leggett JE, Wang L, et al. Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel. Diagn Microbiol Infect Dis. 2021;99(3):115246. [CrossRef]
- Buchan BW, Windham S, Balada-Llasat JM, et al. Practical comparison of the BioFire FilmArray Pneumonia Panel to routine diagnostic methods and potential ımpact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol. 2020;58(7):e00135-20. [CrossRef]
- Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); 2006. [güncelleme Ekim 2022; erişim 13 Ağustos 2024]. https://www.cdc.gov/infection-control/hcp/mdro-management/index.html
- Murphy CN, Fowler R, Balada-Llasat JM, et al. Multicenter evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol. 2020;58(7):e00128-20. [CrossRef]
- Webber DM, Wallace MA, Burnham CA, Anderson NW. Evaluation of the BioFire FilmArray Pneumonia Panel for detection of viral and bacterial pathogens in lower respiratory tract specimens in the setting of a tertiary care academic medical center. J Clin Microbiol. 2020;58(7):e00343-20. [CrossRef]
- Ginocchio CC, Garcia-Mondragon C, Mauerhofer B, Rindlisbacher C; and the EME Evaluation Program Collaborative. Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing. Eur J Clin Microbiol Infect Dis. 2021;40(8):1609-22. [CrossRef]
- Verroken A, Favresse J, Anantharajah A, Rodriguez-Villalobos H, Wittebole X, Laterre PF. Optimized antibiotic management of critically ill patients with severe pneumonia following multiplex polymerase chain reaction testing: A prospective clinical exploratory trial. Antibiotics (Basel). 2024;13(1):67. [CrossRef]
- Winter R, Parvati I, Sugianli AK. Identification of community- and hospital-acquired pulmonary bacterial infection using culture and PCR panel in COVID-19. Indones J Clin Pathol Med Lab. 2024;30(2):153-8.
- Arıkan S; Klinik Mikrobiyoloji Uzmanlık Derneği (KLIMUD). Solunum sistemi örneklerinin laboratuvar incelemesi rehberi. 2nd ed. Ankara: KLIMUD; 2022. 72 p.
- Szymankiewicz MT, Szczepanska A, Stefaniuk E. Evaluation of the BioFire® FilmArray® Pneumonia plus Panel for detecting bacterial etiological agents of lower respiratory tract infections in an oncologic hospital. Comparison with conventional culture method. Pol J Microbiol. 2023;72(4):391-8. [CrossRef]
- Hanson KE, Azar MM, Banerjee R, et al. Molecular testing for acute respiratory tract infections: Clinical and diagnostic recommendations from the IDSA’s Diagnostics Committee. Clin Infect Dis. 2020;71(10):2744-51. [CrossRef]
- Richardson L, Brite J, Del Castillo M, et al. Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy. Clin Microbiol Infect. 2016;22(4):380.e1-e7. [CrossRef]
- University of Nebraska Medical Center. Guidance on use of the pneumonia panel for respiratory infections [Internet]. Omaha: University of Nebraska Medical Center. [erişim 25 Şubat 2025]. https://www.unmc.edu/intmed/_documents/id/asp/clinicpath-pneumonia-panel-guideline.pdf
- Chen CL, Tseng HY, Chen WC, et al. Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units. J Microbiol Immunol Infect. 2024;57(3):480-9. [CrossRef]
- Plattner AS, Lockowitz CR, Dumm R, Banerjee R, Newland JG, Same RG. Practice versus potential: The impact of the BioFire FilmArray Pneumonia Panel on antibiotic use in children. J Pediatric Infect Dis Soc. 2024;13(3):196-202. [CrossRef]
- Chambe E, Bortolotti P, Diesnis R, et al. Performance and impact on antibiotic prescriptions of a multiplex PCR in a real-life cohort of critically ill patients with suspected ventilated pneumonia: A retrospective monocentric observational study. Antibiotics (Basel). 2023;12(12):1646. [CrossRef]
- Bozan G, Kara Y, Kiral E, et al. Supporting clinical decisions with rapid molecular diagnostic pneumonia panel in pediatric intensive care unit: Single center experience in Turkiye. Microorganisms. 2023;11(10):2391. [CrossRef]
- Dalfino L, Stufano M, Bavaro DF, et al. Effectiveness of first-line therapy with old and novel antibiotics in ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii: A real life, prospective, observational, single-center study. Antibiotics (Basel). 2023;12(6):1048. [CrossRef]
- Gong J, Yang J, Liu L, et al. Evaluation and clinical practice of pathogens and antimicrobial resistance genes of BioFire FilmArray Pneumonia panel in lower respiratory tract infections. Infection. 2024;52(2):545-55. Erratum in: Infection. 2024;52(2):705. [CrossRef]
- Keske Ş, Gümüş T, Köymen T, Sandıkçı S, Tabak L, Ergönül Ö. Human metapneumovirus infection: Diagnostic impact of radiologic imaging. J Med Virol. 2019;91(6):958-62. [CrossRef]
- Zhang JH, Chou SF, Wang PH, et al. Optimizing patient outcomes in severe pneumonia: the role of multiplex PCR in the treatment of critically ill patients. Front Med (Lausanne). 2024;11:1391641. [CrossRef]
- Virk A, Strasburg AP, Kies KD, et al. Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial. Lancet Microbe. 2024;5(12):100928. [CrossRef]
- Bittmann MC, Micek ST, Kollef MH. Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e181. [CrossRef]
- Madaras-Kelly K, Jones M, Remington R, et al. Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare Administration. J Antimicrob Chemother. 2016;71(2):539-46. [CrossRef]
- Hacettepe Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı. Erişkinde pnömoni tanısı [Internet]. Ankara: Hacettepe Üniversitesi. [erişim 13 Ağustos 2024]. https://enfeksiyon.hacettepe.edu.tr/tr/menu/2pnomoni_-81